Targeted hyperthermia in prostate with an MR-guided endorectal ultrasound phased array: patient specific modeling and preliminary experiments

Vasant A. Salgaonkar; Punit Prakash; Juan Plata; Andrew Holbrook; Viola Rieke; John Kurhanewicz; I-C. Hsu; Chris J. Diederich

doi:10.1117/12.2004609

26 February 2013 Targeted hyperthermia in prostate with an MR-guided endorectal ultrasound phased array: patient specific modeling and preliminary experiments

Vasant A. Salgaonkar, Punit Prakash, Juan Plata, Andrew Holbrook, Viola Rieke, John Kurhanewicz, I-C. Hsu, Chris J. Diederich

Author Affiliations +

Proceedings Volume 8584, Energy-based Treatment of Tissue and Assessment VII; 85840U (2013) https://doi.org/10.1117/12.2004609
Event: SPIE BiOS, 2013, San Francisco, California, United States

Abstract

Feasibility of hyperthermia delivery to the prostate with a commercially available MR-guided endorectal ultrasound (ERUS) phased array ablation system (ExAblate 2100, Insightec, LTD) was assessed through computer simulations and ex vivo experiments. The simulations included a 3D FEM-based biothermal model, and acoustic field calculations for the ExAblate phased array (2.3 MHz, 2.3x4.0 cm²) using the rectangular radiator method. Array beamforming strategies were investigated to deliver 30-min hyperthermia (<41 °C) to focal regions of prostate cancer, identified from MR images in representative patient cases. Constraints on power densities, sonication durations and switching speeds imposed by ExAblate hardware and software were incorporated in the models. T<41 °C was calculated in 14-19 cm³ for sonications with planar or diverging beam patterns at 0.9-1.2 W/cm², and in 3-10 cm3 for curvilinear (cylindrical) or multifocus beam patterns at 1.5-3.3 W/cm², potentially useful for treating focal disease in a single posterior quadrant. Preliminary experiments included beamformed sonications in tissue mimicking phantom material under MRI-based temperature monitoring at 3T (GRE TE=7.0 ms, TR=15 ms, BW=10.5 kHz, FOV=15 cm, matrix 128x128, FA=40°). MR-temperature rises of 2-6 °C were induced in a phantom with the ExAblate array, consistent with calculated values and lower power settings (~0.86 W/cm², 3 min.). Conformable hyperthermia may be delivered by tailoring power deposition along the array length and angular expanse. MRgERUS HIFU systems can be controlled for continuous hyperthermia in prostate to augment radiotherapy and drug delivery. [FUS Foundation, NIH R01 122276, 111981].

Citation Download Citation

Vasant A. Salgaonkar, Punit Prakash, Juan Plata, Andrew Holbrook, Viola Rieke, John Kurhanewicz, I-C. Hsu, and Chris J. Diederich "Targeted hyperthermia in prostate with an MR-guided endorectal ultrasound phased array: patient specific modeling and preliminary experiments", Proc. SPIE 8584, Energy-based Treatment of Tissue and Assessment VII, 85840U (26 February 2013); https://doi.org/10.1117/12.2004609

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available